Luke Harada

Luke Harada is the Chief Operating Officer at SonoVascular, Inc., leading the development of innovative medical technology aimed at treating venous and arterial diseases. Since 2022, Luke has also provided strategic advisory consulting services through OneMedTech Advisors LLC. Previously, Luke held key leadership roles in corporate development at prominent medical device companies such as Hillrom, BD, and CR Bard, where responsibilities included mergers and acquisitions, as well as business development initiatives. Additional experience includes serving as an Investment Partner at Mitsui & Co. Global Investment and various roles at Johnson & Johnson, where significant achievements included securing a worldwide exclusive license for the CYPHER™ drug-eluting stent. Luke's career commenced at Merrill Lynch & Co., where leadership in M&A and strategic advisory was demonstrated. Luke holds a JD from Northwestern University Pritzker School of Law, an MBA from Northwestern University Kellogg School of Management, and a BA in Economics from Harvard University.